2012 CSHL Retroviruses Conference

描述（由申请人提供）：本提案寻求对将在冷泉港实验室举行的关于“逆转录病毒”的年度系列会议中的第三十七次会议的支持，该会议已成为该领域的首要会议。拟议的会议将聚集在该领域的领导人，初级教师，博士后研究员和研究生讨论新的，在逆转录病毒生物学领域的前沿发展。该系列会议的重点是病毒及其与宿主细胞的相互作用，而不是它们引起的特定疾病。绝大多数的工作将被提交未发表，并立即评论和讨论的观众。2012年会议的结构将与病毒的生物学相平行;从复制周期的进入阶段开始，进行进入后事件，包括逆转录和整合，RNA相关事件（转录，加工，输出和包装），颗粒组装和释放，发病机制/宿主因素，并以抗病毒药物和进化结束。选定的演讲者将包括研究生，博士后研究员和初级教师。每次会议将由组织者从登记者中选出的该领域的两名主要科学家主持。两位杰出的特邀演讲者将发表特别演讲，以激励和告知年轻科学家，并激发从事相关但不同领域工作的科学家之间的讨论。还将有三个海报会议，大多数与会者可以介绍他们的工作。会议将是中等规模，我们预计约450逆转录病毒学家出席。

DESCRIPTION (provided by applicant): This proposal seeks support for the thirty-seventh in an annual series of meetings on "Retroviruses" to be held at Cold Spring Harbor Laboratory that has emerged as the premiere conference for this field. The proposed meeting will assemble leaders in the field, junior faculty, postdoctoral fellows and graduate students to discuss new, cutting-edge developments in the field of retrovirus biology. The meeting series is focused on the viruses and their interactions with host cells rather than the particular diseases they cause. The large majority of the work to be presented will be unpublished and subject to immediate comment and discussion by the audience. The 2012 meeting will be structured in a manner that parallels the biology of the viruses; beginning with the entry phase of the replication cycle, proceeding with post-entry events, including reverse transcription and integration, RNA-related events (transcription, processing, export, and packaging), particle assembly and release, pathogenesis/host factors, and concluding with antivirals and evolution. Selected speakers will include graduate students, postdoctoral fellows and junior faculty. Each session will be chaired by two leading scientists in the field selected by the organizers from among the registrants. Two eminent invited speakers will give special lectures to inspire and inform young scientists and to stimulate discussion between scientists working on related but distinct areas. There will also be three poster sessions where a majority of participants can present their work. The meeting will be of moderate size, and we expect ~450 retrovirologists in attendance.